Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...

Bhaktapur district has been identified as a high-risk area for both HIV/AIDS transmission and drug abuse, according to data ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...

A report by Ghana HIV and AIDS Network (GHANET), as part of its Community HIV self-testing project, has revealed that petty ...

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

A non-reactive result in an HIV test generally means that you don't have HIV. It may also mean you tested too soon after ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...